Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Initial Findings from a High Genetic Risk Prostate Cancer Clinic.

Urology - 1 Oct 2021

Sessine Michael S, Das Sanjay, Park Bumsoo, Salami Simpa S, Kaffenberger Samuel D, Kasputis Amy, Solorzano Marissa, Luke Mallory, Vince Randy A, Kaye Deborah R, Borza Tudor, Stoffel Elena M, Cobain Erin, Merajver Sofia D, Jacobs Michelle F, Milliron Kara J, Caba Laura, van Neste Leander, Mondul Alison M, Morgan Todd M

Abstract excerpt

OBJECTIVE: To improve prostate cancer screening for high-risk men, we developed an early detection clinic for patients at high genetic risk of developing prostate cancer. Despite the rapidly growing understanding of germline variants in driving aggressive prostate cancer and the increased availability of genetic testing, there is little evidence surrounding how best to screen these men. METHODS: We are reporting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Checkpoint Kinase 2
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Life Style

Share to Medical History Taking

Share to Nutrition Surveys

Share to Prostate

Share to Prostate-Specific Antigen

Share to Urinalysis

Source

Identifiers

PMID: 34280438
DOI: 10.1016/j.urology.2021.05.078

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Initial Findings from a High Genetic Risk Prostate Cancer Clinic.PMID 34280438Read ↗

Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials ConsortiumSemantic proximity Read ↗

Germline Genetics of Prostate Cancer: Time to Incorporate Genetics into Early Detection ToolsSemantic proximity Read ↗

Inherited Mutations in Men Undergoing Multigene Panel Testing for Prostate Cancer: Emerging Implications for Personalized Prostate Cancer Genetic EvaluationSemantic proximity Read ↗

Prostate Cancer Screening in a New Era of Genetics.Semantic proximity Read ↗

Genetic testing in prostate cancer management: Considerations informing primary care.Semantic proximity Read ↗

Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease ManagementSemantic proximity Read ↗

Diagnosing hereditary cancer predisposition in men with prostate cancer.Semantic proximity Read ↗

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is NowSemantic proximity Read ↗

The role of genetic testing in prostate cancer screening, diagnosis, and treatment.Semantic proximity Read ↗

Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.Semantic proximity Read ↗

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing GuidelinesSemantic proximity Read ↗

Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.